ReviewFrontiers in neurology

Microbiota and Guillain-Barré syndrome: role of microbial metabolites, biomarkers, and emerging therapeutic strategies.

María Zurdo-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.